Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event
NCT00347217 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3840
Last updated 2011-08-30
Summary
Observational study to investigate the use and efficacy of CRESTOR 5 mg in reaching LDL-C target goals in both statin naïve and statin treated primary and secondary prevention patients at high risk for a cardiovascular event.
Conditions
- Hypercholesteremia
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
AstraZeneca Netherlands Medical Director, MD · AstraZeneca
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-02-28
- Completion
- 2009-01-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)
NCT00240266 ·Status: COMPLETED ·Phase: PHASE3
-
A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)
NCT00240318 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease
NCT00296374 ·Status: COMPLETED ·Phase: PHASE2
-
Crestor Versus Placebo in Subjects With Heart Failure
NCT00206310 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease
NCT00296400 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-541468 Can Affect the Fate in the Body (Amount and Time of Presence in the Blood) of Rosuvastatin
NCT03339752 ·Status: COMPLETED ·Phase: PHASE1
-
Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions
NCT01241903 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Efficacy of Rosuvastatin in Daily Practice (TARGET)
NCT00396110 ·Status: COMPLETED
-
Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
NCT00296387 ·Status: COMPLETED ·Phase: PHASE3
-
COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects
NCT00654485 ·Status: COMPLETED ·Phase: PHASE3
-
A Diabetes Study to Treat A Population Previously Not at Target
NCT00747149 ·Status: COMPLETED ·Phase: PHASE4
-
C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients
NCT00688454 ·Status: COMPLETED
-
Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart Disease
NCT00235950 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome
NCT00240305 ·Status: COMPLETED ·Phase: PHASE3
-
LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients
NCT02077257 ·Status: UNKNOWN ·Phase: PHASE4
-
Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)
NCT00660764 ·Status: COMPLETED
-
Rosuvastatin Pre-Treatment Influences the Risk of Coronary Intervention Study
NCT01378715 ·Status: UNKNOWN ·Phase: PHASE3
-
Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic Syndrome
NCT00335699 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial
NCT06856772 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)
NCT00574782 ·Status: COMPLETED
-
A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-132577 Can Affect Rosuvastatin's Fate in the Body (Amount and Time of Presence in the Blood)
NCT03245229 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
NCT00665834 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary Syndrome
NCT04056169 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia
NCT02445352 ·Status: COMPLETED ·Phase: PHASE3
-
Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia
NCT01352897 ·Status: COMPLETED